HAGLR and gastric cancer: Another study implicated the role of lncRNA HOXD cluster antisense RNA 1 (HOXD-AS1), whose knockdown in cisplatin-resistant gastric cancer cells (BGC823/DDP and SGC7901/DDP) increased their sensitivity to cisplatin treatment.